A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Launched by MCMASTER UNIVERSITY · Apr 20, 2017
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The RADICAL PC clinical trial is studying how to improve the heart health and lifestyle of men who have recently been diagnosed with prostate cancer. This trial aims to help patients manage not just their prostate cancer but also any risks related to heart disease and other lifestyle factors. If you are a man diagnosed with prostate cancer within the past year, or if you have started treatment for it recently, you may be eligible to participate.
In this study, researchers will look for ways to support men in making healthy changes that could benefit both their cancer treatment and overall well-being. To join, participants need to be 45 years or older and must be willing to provide consent to be part of the study. Those who have certain heart conditions or are already receiving specific treatments may not be able to participate in all parts of the trial. If you decide to take part, you can expect to work closely with healthcare professionals who will guide you through the process and help you make positive lifestyle changes.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- 1. A man with a diagnosis of prostate cancer that is either:
- • new (i.e. the diagnosis was made within 1 year of the enrolment visit) or
- • treated with Androgen Deprivation Therapy for the first time within 6 months prior to the enrolment visit, or
- • to be treated with Androgen Deprivation Therapy for the first time within 1 month after the enrolment visit
- Exclusion Criteria:
- 1. Patients will be excluded if they fulfill any of the following:
- • 1. are unwilling to provide consent or
- • 2. are \<45 years of age, or
- • 3. prostate cancer was found incidentally following cystectomy for bladder cancer
- 2. Patients will be eligible for RADICAL PC1, but will not be eligible for RADICAL PC2 if they:
- • 1. see a cardiologist every year, or
- • 2. both take a statin and have systolic blood pressure ≤130mmHg
About Mcmaster University
McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Kansas, United States
Adelaide, South Australia, Australia
Westmead, New South Wales, Australia
Vancouver, British Columbia, Canada
Toronto, Ontario, Canada
Montreal, Quebec, Canada
Ottawa, Ontario, Canada
Hamilton, Ontario, Canada
Waratah, New South Wales, Australia
Adelaide, South Australia, Australia
London, Ontario, Canada
Porto Alegre, Rio Grande Do Sul, Brazil
Petach Tikva, , Israel
Montréal, Quebec, Canada
Floridablanca, Santander, Colombia
Istanbul, , Turkey
São José Do Rio Preto, São Paulo, Brazil
Augusta, Georgia, United States
São José Do Rio Preto, , Brazil
Brampton, Ontario, Canada
Quebec City, Quebec, Canada
Ijuí, Rio Grande Do Sul, Brazil
Hamilton, Ontario, Canada
Kingston, Ontario, Canada
Kitchener, Ontario, Canada
London, Ontario, Canada
Niagara, Ontario, Canada
Toronto, Ontario, Canada
Montreal, Quebec, Canada
Montréal, Quebec, Canada
Belo Horizonte, Minas Gerais, Brazil
São Paulo, , Brazil
Porto Alegre, Rio Grande Do Sul, Brazil
Bogotá, Cundinamarca, Colombia
Votuporanga, São Paulo, Brazil
Uberaba, Minas Gerais, Brazil
Campina Grande Do Sul, Paraná, Brazil
Botucatu, São Paulo, Brazil
Jaú, São Paulo, Brazil
São Paulo, , Brazil
São Paulo, , Brazil
São Paulo, , Brazil
São Paulo, , Brazil
São Paulo, , Brazil
Sherbrooke, Quebec, Canada
Holon, , Israel
Tel Aviv, , Israel
Votuporanga, , Brazil
Rio De Janeiro, , Brazil
Brasilia, Df, Brazil
Campo Largo, Paraná, Brazil
Curitiba, Paraná, Brazil
Recife, Pernambuco, Brazil
Porto Alegre, Rio Grande Do Sul, Brazil
Bragança Paulista, São Paulo, Brazil
São Paulo, , Brazil
São Paulo, , Brazil
Cali, Valle Del Cauca, Colombia
Barueri, Sao Paulo, Brazil
Campina Grande Do Sul, , Brazil
Campo Largo, , Brazil
Curitiba, , Brazil
Botucatu, , Brazil
Bragança Paulista, , Brazil
Jaú, , Brazil
Patients applied
Trial Officials
Dr. Darryl Leong, MBBs,MPH,PhD,FRACP,FESC
Study Director
McMaster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials